N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide

C13H11N5O2 — CID 104620146

IUPACN-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide
SMILESCc1cn[nH]c1NC(=O)c1ccc(-c2nnco2)cc1
InChIInChI=1S/C13H11N5O2/c1-8-6-14-17-11(8)16-12(19)9-2-4-10(5-3-9)13-18-15-7-20-13/h2-7H,1H3,(H2,14,16,17,19)
InChIKeyFXNGAKAGPNFADB-UHFFFAOYSA-N
MW269.26 g/mol
LogP2.02
Rot. Bonds3

About N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide

N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide (PubChem CID 104620146) has the molecular formula C13H11N5O2 and a molecular weight of 269.26 g/mol. Its IUPAC name is N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide.

Molecular Properties

Compound NameN-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide
PubChem CID104620146
Molecular FormulaC13H11N5O2
Molecular Weight269.26 g/mol
Exact Mass269.09
IUPAC NameN-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide
SMILESCc1cn[nH]c1NC(=O)c1ccc(-c2nnco2)cc1
InChIInChI=1S/C13H11N5O2/c1-8-6-14-17-11(8)16-12(19)9-2-4-10(5-3-9)13-18-15-7-20-13/h2-7H,1H3,(H2,14,16,17,19)
InChIKeyFXNGAKAGPNFADB-UHFFFAOYSA-N
XLogP2.02
TPSA96.70 Ų
H-Bond Donors2
H-Bond Acceptors5
Rotatable Bonds3
Heavy Atoms20
Complexity

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500269.26
LogP ≤ 52.02
H-Bond Donors ≤ 52
H-Bond Acceptors ≤ 105

Analyze N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide?
The IUPAC name of N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide (CID 104620146) is N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide.
What is the SMILES notation for N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide?
The canonical SMILES for N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide is Cc1cn[nH]c1NC(=O)c1ccc(-c2nnco2)cc1.
What is the InChIKey of N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide?
The InChIKey is FXNGAKAGPNFADB-UHFFFAOYSA-N. The full InChI is InChI=1S/C13H11N5O2/c1-8-6-14-17-11(8)16-12(19)9-2-4-10(5-3-9)13-18-15-7-20-13/h2-7H,1H3,(H2,14,16,17,19).
What are the key properties of N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide?
N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide has a molecular weight of 269.26 g/mol, XLogP of 2.02, 3 rotatable bonds, 2 hydrogen bond donors, and 5 hydrogen bond acceptors.
Where does this data come from?
All data for N-(4-methyl-1H-pyrazol-5-yl)-4-(1,3,4-oxadiazol-2-yl)benzamide is sourced from PubChem (CID 104620146), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).